Biocheck, Inc Product Pipeline Analysis and Update Till 2016

BioCheck, Inc. - Product Pipeline Analysis, 2016 Update – Size, Share,

Analysis, Forecast, Trends And Growth Report

Summary

BioCheck, Inc. (BioCheck), a subsidiary of OriGene Technologies, Inc. is a medical device

company that develops, manufactures, and distributes enzyme immunoassay test kits and

research reagents for the healthcare and research markets. The company's products include

antibodies, conjugates, enzyme immunoassay kits, research reagents, rabbit monoclonal

antibodies, positive human serum antibodies, torch antigens, diluents, cardiac and tumor

markers, steroids, ID protein reagents, and other reagents, among others. It offers services such

as custom immunoassay development, antibody purification and conjugation, and contract

manufacturing and assembly services. BioCheck offers its products and services to biomedical,

pharmaceutical, and scientific research markets. The company distributes its products to

countries in Central and South America, Europe, the Middle East, and Asia. BioCheck is

headquartered in Foster, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio

of pipeline products. The report provides key information about the company, its major products

and brands.

To Get More Details @ http://www.radiantinsights.com/research/biocheck-inc-productpipeline-analysis-2016-update

The report enhances decision making capabilities and help to create effective counter strategies

to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key

company facts, major products and services, key competitors, key employees, locations and

subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company BioCheck, Inc.

- The report provides pipeline analysis on all pipeline products of the company (by equipment

type, by indication, by development stage, and by trial status)

- The report...